190 related articles for article (PubMed ID: 15963971)
1. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971
[TBL] [Abstract][Full Text] [Related]
2. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure.
Pawlak K; Mysliwiec M; Pawlak D
Cytokine; 2008 Jul; 43(1):98-101. PubMed ID: 18455421
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
Pawlak K; Mysliwiec M; Pawlak D
Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
[TBL] [Abstract][Full Text] [Related]
5. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
[TBL] [Abstract][Full Text] [Related]
7. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
Washio K; Inagaki M; Tsuji M; Morio Y; Akiyama S; Gotoh H; Gotoh T; Gotoh Y; Oguchi K
Nephron Clin Pract; 2008; 109(2):c49-54. PubMed ID: 18544955
[TBL] [Abstract][Full Text] [Related]
8. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients.
Pawlak K; Pawlak D; Myśliwiec M
Med Sci Monit; 2006 Apr; 12(4):CR181-5. PubMed ID: 16572054
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Cytokine; 2004 Dec; 28(6):197-204. PubMed ID: 15566948
[TBL] [Abstract][Full Text] [Related]
10. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
11. Association between tissue factor, its pathway inhibitor and oxidative stress in peritoneal dialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):467-71. PubMed ID: 17581322
[TBL] [Abstract][Full Text] [Related]
12. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
Pawlak K; Pawlak D; Myśliwiec M
Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597
[TBL] [Abstract][Full Text] [Related]
13. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
15. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
[TBL] [Abstract][Full Text] [Related]
17. Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis.
Bibi G; Green Y; Nagler RM
Ther Apher Dial; 2008 Apr; 12(2):164-70. PubMed ID: 18387167
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of superoxide dismutase and its isomers in patients with chronic renal disease.
Futenma A; Yamada H; Kitano M; Miyai H; Fukatsu A; Kato K
Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):371-6. PubMed ID: 8341015
[TBL] [Abstract][Full Text] [Related]
19. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
[TBL] [Abstract][Full Text] [Related]
20. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
